Keuna Jeon

Ms. Keuna Jeon

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2020 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
KJKeuna Jeon
Keuna Jeon
NANesha May O. Andoy
Nesha May O. Andoy
CSChristian W. Schmitt
Christian W. Schmitt
YXYilei Xue
Yilei Xue
LBLeonie Barner
Leonie Barner
RSRuby Sullan
Ruby Sullan
Polyserotonin-based nanoparticles are a new class of bioinspired nanomaterial with recently demonstrated therapeutic potential for future clinical applications. It is therefore important to establish a robust and rapid method of synthesizing polyserotonin nanoparticles (PSeNP) in the size range ideal for in vivo utilization. Since the formation of PSeNP is base-catalyzed, here we report the influence of solution pH, in the presence of different base systems, on the kinetics of PSeNP formation and physico-chemical properties of the resulting nanoparticles. We show that the rate of formation and the size of PSeNP depend on both the nature of the base and the initial pH of the reaction. We have also improved the kinetics of particle formation by performing the synthesis at an elevated temperature (60 °C), leading to a dramatic reduction in synthesis time from days to hours. This presents a significant advance in the efficiency of PSeNP synthesis and provides a facile approach in tuning the size of nanoparticles to suit various applications. Furthermore, we show that similar to serotonin, PSeNP also exhibits free radical scavenging property. Our results demonstrate that PSeNP has the potential to become a key player in the advancement of nanotechnology-mediated antioxidative therapy.

14 November 2023 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
MPMeera Patel
Meera Patel
NANesha May O. Andoy
Nesha May O. Andoy
STSusannah Megan Tran
Susannah Megan Tran
KJKeuna Jeon
Keuna Jeon
RSRuby Sullan
Ruby Sullan
Polydopamine relies on loading method and antibiotic structure for drug delivery.

29 September 2025 in Biofabrication
Verified
Journal Article
Closed access
HNHuu Tuan Nguyen
Huu Tuan Nguyen
ZTZuzana Tirpáková
Zuzana Tirpáková
APArne Peirsman
Arne Peirsman
Surjendu MaitySurjendu Maity
Surjendu Maity
Natashya FalconeNatashya Falcone
Natashya Falcone
VJVadim Jucaud
Vadim Jucaud
Blood vessel embolization is a well-established treatment modality for liver cancer. Novel shear-thinning hydrogels (STH) have been developed to address the need for safer and more effective local delivery of embolic agents and therapeutics. However, embolization therapies are currently optimized in animal models, which often differ from humans at the cellular, tissue, and organ levels. We aim to evaluate the efficacy of novel embolic agents such as STH using a human-relevant in vitro model that recapitulates human hepatocellular carcinoma capillary networks. A vascularized human liver-tumor-on-a-chip model was developed to assess embolic agent performance. The effects of drug-eluting STH (DESTH) on tumor cell viability, surface marker expression, vasculature morphology, and cytokine responses were evaluated. To study the effects of embolization on microvasculature morphology independent of the chemotherapy compound, we evaluated the effect of different drug-free embolic agents on the vascular tumor microenvironment under flow conditions. DESTH treatment induced tumor cell death, downregulated the expression of epithelial cell adhesion molecules in HepG2, increased levels of cytokines such as interleukin-4 (IL-4), granulocyte-macrophage colony-stimulating factor, and vascular endothelial growth factor, and decreased albumin secretion. Furthermore, different embolic agents exert distinct effects on microvascular morphology, with STH causing complete regression of the microvascular networks. This vascularized liver tumor-on-a-chip model enables human-relevant, real-time assessment of embolic agent efficacy and vascular response and can be applied for the development of innovative and effective embolization therapies for liver cancer.

3 March 2023 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
MPMeera Patel
Meera Patel
ACAlexander L. Corbett
Alexander L. Corbett
AVAarushi Vardhan
Aarushi Vardhan
KJKeuna Jeon
Keuna Jeon
NANesha May O. Andoy
Nesha May O. Andoy
RSRuby Sullan
Ruby Sullan
Precise control of antimicrobial delivery can prevent the adverse effects of antibiotics.

13 June 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
KJKeuna Jeon
Keuna Jeon
JAJustin Andrei Asuncion
Justin Andrei Asuncion
ACAlexander Lucien Corbett
Alexander Lucien Corbett
TYTiange Yuan
Tiange Yuan
MPMeera Patel
Meera Patel
RSRuby Sullan
Ruby Sullan
Polyserotonin nanoparticles (PSeNP) and films are bioinspired nanomaterials that have potential in biomedical applications and surface coatings. As studies on polyserotonin (PSe) nanoparticles and films are still in their infancy, synthetic pathways and material development for this new class of nanomaterial await investigation. Here, we sought to determine how different buffers used during the polymerization of serotonin to form nanoparticles and films impact the physicochemical properties of PSe materials. We show that buffer components are incorporated into the polymer matrix, which is also supported by density functional theory calculations. While we observed no significant differences between the elasticity of nanoparticles synthesized in the different buffers, the nanoscale surface properties of PSe films revealed dissimilarities in surface functional groups influenced by solvent molecules. Overall, the results obtained in this work can be used towards the rational design of PSe nanomaterials with tailored properties and for specific applications.

9 June 2026 in Materials Today Bio
Verified
Journal Article
Open access
KJKeuna Jeon
Keuna Jeon
UKUijin Kim
Uijin Kim
CJChang-Hun Ji
Chang-Hun Ji
MKMeenakshi Kamaraj
Meenakshi Kamaraj
NLNoah Zachary Laird
Noah Zachary Laird
Natashya FalconeNatashya Falcone
Natashya Falcone
The tumor microenvironment (TME) is a dynamic and heterogeneous ecosystem in which cancer, stromal, immune, and physicochemical components collectively regulate disease progression and therapeutic response. Recent evidence further indicates that intratumoral bacteria are active contributors to tumor metabolism, immune modulation, and treatment outcomes, revealing a previously underexplored multi-kingdom dimension of solid tumors. However, mechanistic understanding of tumor–microbe interactions remain limited by the absence of experimental platforms that integrate microbial components into physiologically relevant and controllable tumor models. Here, we propose bacteria-integrated tumor microenvironments as an emerging bioengineering framework for modeling cancer as a multi-kingdom system with biomaterials. We first lay out the existence of bacteria in our body and outline key design principles for these systems, including control of microbial localization, nutrient and oxygen gradients, and interkingdom signaling within engineered matrices. We further discuss applications in studying microbial contributions to therapeutic resistance, evaluating engineered bacterial therapies, and developing patient-specific tumor–microbiome models for precision oncology. Finally, we highlight challenges in standardizing multi-kingdom tumor platforms and integrating them with advanced imaging, sequencing, and computational tools. Collectively, bacteria-integrated TME establish a new paradigm for engineering cancer as a multi-kingdom system with translational potential in oncology.